Drug Trial Radar · NCT00544960
A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: Aug 27, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
106
Actual
Start
Sep 2007
Primary completion
Nov 2008
Study completion Apr 2009
Sponsor
- Lead sponsor
- Ascenta TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 16, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double- blind, multicenter, randomized Phase II study to evaluate the efficacy and safety of AT-101 in combination with docetaxel in relapsed/refractory non-small cell lung cancer
Conditions
- Non-small Cell Lung Cancer
Interventions
AT-101 and docetaxelDrug
AT-101 30 mg bid on days 1, 2, and 3 of each 21 day cycle, docetaxel, 75 mg/m2 on day 1 of each 21 day cycle; until progression or unacceptable toxicity develops
placebo and docetaxelDrug
placebo 3 tabs bid on days 1, 2, and 3 of each 21 day cycle, docetaxel, 75 mg/m2 on day 1 of each 21 day cycle; until progression or unacceptable toxicity develops
Primary outcomes
What the sponsor says the trial is designed to measure.
- duration of disease remissionTime frame: 12 months
Locations
18 sites in 3 countries. Site status is shown where the registry gives one.
Research Site
Durham, North Carolina
Research Site
Arkhangelsk, Russia
Research Site
Chelyabinsk, Russia
Research Site
Kaliningrad, Russia
Research Site
Kazan', Russia
Research Site
Moscow, Russia
Research Sites (4)
Saint Petersburg, Russia
Research Site
Samara, Russia
Research Site
Stavropol, Russia
Research Site
Voronezh, Russia
Research Site
Yekaterinburg, Russia
Research Site
Dnipropetrovsk, Ukraine
Research Site
Donetsk, Ukraine
Research Site
Kharkiv, Ukraine
Research Site
Kyiv, Ukraine
Research Site
Luhansk, Ukraine
Research Site
Uzhhorod, Ukraine
Research Site
Zaporizhzhya, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.